US 11007186
Methods of treating RBP4 related diseases with triazolopyridines
granted A61KA61K31/4545A61K31/4985
Quick answer
US patent 11007186 (Methods of treating RBP4 related diseases with triazolopyridines) held by Belite Bio, Inc expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Belite Bio, Inc
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4545, A61K31/4985, A61K31/519, A61K31/5365